Belvedere Trading LLC Cardiff Oncology, Inc. Call Options Transaction History

Belvedere Trading LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Jan 25, 2022	SELL	$5.18 - $7.24 $83,398 - $116,564	-16,100 Closed	0 $0
Q3 2021 Oct 19, 2021	BUY	$5.01 - $7.58 $80,661 - $122,038	16,100 New	16,100 $99,000
Q2 2021 Jul 23, 2021	SELL	$6.65 - $10.04 $63,840 - $96,383	-9,600 Closed	0 $0
Q1 2021 Apr 27, 2021	BUY	$9.1 - $19.57 $2,730 - $5,871	300 Added 3.23%	9,600 $89,000
Q4 2020 Feb 10, 2021	BUY	$12.02 - $24.71 $111,786 - $229,803	9,300 New	9,300 $167,000

125

25.3M

866K

203K

Ticker CRDF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,334,900
Market Cap $175M
Description
Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; meta...

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Belvedere Trading LLC with notifications on news.